Myocardial contrast echocardiography in the assessment of patients with chronic coronary artery disease

被引:1
|
作者
de Isla, LP [1 ]
Serra, V [1 ]
Rodrigo, JL [1 ]
Almería, C [1 ]
Aubele, A [1 ]
Zamorano, JL [1 ]
机构
[1] Hosp Clin San Carlos, Inst Cardiovasc, Lab Ecocardiog, Madrid 28040, Spain
关键词
contrast echocardiography; myocardial perfusion; echo contrast agents;
D O I
10.1046/j.1540-8175.20.s1.5.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The development of new contrast agents and new imaging methods has lead to an emerging field of applications for myocardial contrast echocardiography (MCE) in patients suffering from chronic ischemic heart disease. Echo contrast allows the assessment of myocardial perfusion (MP) by imaging the coronary microcirculation. Several echocardiographic modalities are available, the main difference between them being the acoustic power needed to perform the study. MP is evaluated by assessing the changes in myocardial videointensity that occur after intravenous contrast injection. Evaluation of these patients is performed by using different techniques. Evaluation of coronary stenosis may be performed by using stress tests or without its use. Coronary artery stenosis >50% of the coronary luminal diameter reveals a decreased hyperemic response when myocardial oxygen demand is increased. Different methods to evaluate the presence of relevant coronary stenosis have been developed: evaluation of myocardial blood flow reserve, evaluation of myocardial blood volume, and evaluation of the transmural distribution of myocardial blood flow. The combination of wall motion analysis with MCE assessment has been demonstrated to achieve the best balance between sensitivity (86%) and specificity (88%), with the highest accuracy (86%). Without the need of any stress, the ratio systolic/diastolic myocardial blood volume has been described to increase with the presence of a epicardial coronary stenosis and it may be measured by MCE. Myocardial viability is also one of the potentials of MCE. Microvascular integrity, demonstrated by MCE, is an indicator of preserved viability and predicts functional recovery that has been validated in the setting of chronic left ventricular dysfunction secondary to chronic coronary artery disease and in the setting of post acute myocardial infarction left ventricular dysfunction. In conclusion: contrast echocardiography provides an interesting tool that offers the potential of a complete evaluation of patients with chronic coronary artery disease. This includes both diagnostic and prognostic evaluation.
引用
收藏
页码:S31 / S42
页数:12
相关论文
共 50 条
  • [31] CONTRAST PERFUSION ECHOCARDIOGRAPHY - DISTRIBUTION AND REPRODUCIBILITY OF MYOCARDIAL CONTRAST ENHANCEMENT IN CORONARY-ARTERY DISEASE
    GRIFFIN, B
    TIMMIS, AD
    SOWTON, E
    AMERICAN JOURNAL OF CARDIOLOGY, 1987, 60 (07): : 538 - 543
  • [33] Potential clinical applications of myocardial contrast echocardiography in evaluating myocardial perfusion in coronary artery disease
    Aggeli, C
    Bonou, M
    Stefanadis, C
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 104 (01) : 1 - 9
  • [34] Myocardial contrast echocardiography accurately predicted coronary artery disease in patients presenting with acute heart failure
    Janardhanan, R
    Hickman, M
    Lahiri, A
    Senior, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 9A - 9A
  • [35] Microvascular structural correlates of myocardial contrast echocardiography in patients with coronary artery disease and ventricular dysfunction.
    Shimoni, S
    Frangogiannis, NG
    Aggeli, CJ
    Shan, K
    Nagueh, SF
    Reardon, MJ
    Espada, R
    Letsou, GV
    Quinones, MA
    Zoghbi, WA
    CIRCULATION, 2000, 102 (18) : 748 - 748
  • [36] Collateral vessels assessed by myocardial contrast echocardiography in patients with coronary artery lesions after Kawasaki disease
    Kinoshita, Y
    Suzuki, A
    Nakajima, T
    Ono, Y
    Arakaki, Y
    Kamiya, T
    HEART AND VESSELS, 1996, 11 (04) : 203 - 210
  • [37] Myocardial contrast echocardiography in conjunction with dipyridamole thallium SPECT in assessing myocardial perfusion in patients with suspected coronary artery disease
    Zabalgoitia, M
    Erikson, J
    Oraby, MA
    Delgado, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 411A - 411A
  • [38] Incremental benefit of myocardial contrast to combined dipyridamole-exercise stress echocardiography for the assessment of coronary artery disease
    Moir, S
    Haluska, BA
    Jenkins, C
    Fathi, R
    Marwick, TH
    CIRCULATION, 2004, 110 (09) : 1108 - 1113
  • [39] The value of real-time myocardial contrast echocardiography for detecting coronary microcirculation function in coronary artery disease patients
    Sun, Lulu
    Wang, Zilong
    Xu, Tongda
    Pan, Defeng
    Liang, Li
    Hao, Ji
    Wang, Xiaoping
    Li, Dongye
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2018, 19 (01): : 27 - 33
  • [40] Feasibility of myocardial perfusion assessment with contrast echocardiography: can it improve recognition of significant coronary artery disease in the ICU?
    Sam Orde
    Michel Slama
    Faraz Pathan
    Stephen Huang
    Anthony Mclean
    Critical Care, 23